Ces radiol. 2017, 71(4):312-322 | DOI: 10.55095/CesRadiol2017/043

31P and 19F MR spectroscopy and imaging in IKEMReview article

Petr Šedivý, Vít Herynek, Monika Dezortová, Miloslav Drobný, Andrea Gálisová, Milan Hájek
Oddělení klinické a experimentální MR spektroskopie, Pracoviště radiodiagnostiky a intervenční radiologie, Institut klinické a experimentální medicíny, Praha

The paper describes the possibility of the application of MR spectroscopy with X-nuclei and is focused to 31P and 19F in vivo MR experiments. Basic procedures of the rest and dynamic 31P MRS are shown on examples of examinations performed in IKEM. 31P and 19F in vivo and in vitro experiments with organs and small animals are demonstrated at 1.5 T, 3 T and 4.7 T magnetic fields. The development of these methods in IKEM is supported by published papers.

Keywords: X-nuclei MR spectroscopy, dynamic and rest 31P MR spectroscopy, 19F MRS
Grants and funding:

Podpořeno MZ ČR - RVO (Institut klinické a experimentální medicíny - IKEM, IČ 00023001) a Grantovou agenturou UK projekt č. 315.

Accepted: November 15, 2017; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šedivý P, Herynek V, Dezortová M, Drobný M, Gálisová A, Hájek M. 31P and 19F MR spectroscopy and imaging in IKEM. Ces radiol. 2017;71(4):312-322. doi: 10.55095/CesRadiol2017/043.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bottomley PA, Edelstein WA, Foster TH, Adams WA. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism? Proc Natl Acad Sci USA 1985; 82(7): 2148-2152. Go to original source... Go to PubMed...
    2. Gladys H, Fuller J. Nuclear spins and moments. Phys Chem Ref 1976; 5: 835. Go to original source...
    3. Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M. Etiology and Functional Status of Liver Cirrhosis by 31P MR Spectroscopy. World J Gastroenterol 2005; 11(44): 6926-6931. Go to original source... Go to PubMed...
    4. Hájek M, Palyzová D, Kořínek M, Kurková D. Concentrations of free Mg2+, pH and 31P MR Metabolite Ratios in Calf Muscles of Healthy Controls and Patients with Primary Juvenile Hypertension. Physiol Res 2002; 51: 159-167. Go to original source...
    5. Kemp GJ, Radda GK. Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q 1994; 10(1): 43-63.
    6. Argov Z, Bank WJ, Maris J, Peterson P, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987; 37(2): 257-262. Go to original source... Go to PubMed...
    7. Kemp GJ, Ahmad RE, Nicolay K, Prompers JJ. Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review. Acta Physiol 2015; 213(1): 107-144. Go to original source... Go to PubMed...
    8. Hájek M, Šedivý P, Kovář J, Dezortová M. Dynamická in vivo 31P MR spektroskopie člověka. Chem Listy 2017; 111: 516-523.
    9. Hájek M, Horská A, Belán A, Táborský P, Grosmanová A. Application of 31P MR spectroscopy for study of human muscles in vivo (Czech). Prakt. Lék. 1990; 70: 538-544.
    10. Táborský P, Sotorník I, Kašlíková J, et al. Uremická myopatie v obraze magnetické resonanční spektroskopie. Prakt. Lék. 1991; 71: 303-306.
    11. Táborský P, Sotorník I, Kašlíková J, et al. 31P Magnetic resonance spectroscopy investigation of skeletal muscle metabolism in uraemic patients. Nephron 1993; 65: 222-226. Go to original source... Go to PubMed...
    12. Hájek M, Grosmanová A, Horská A, et al. Initial clinical experience using the method of 31P MR spectroscopy in investigations of neuromuscular diseases in children. Čes Slov Neurol N 1991; 54/87: 149-156.
    13. Hájek M, Grosmanová A, Horská A, Urban P. Comparison of the clinical state and its changes in patients with Duchenne and Becker muscular dystrophy with results of in vivo 31P magnetic resonance spectroscopy. Eur Radiol 1993; 3(6): 499-506. Go to original source...
    14. Kratochvílová S, Vyhnanovská P, Vlasáková Z, et al. Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents. Metabolism: Clinical and Experimental 2006; 55(10): 1388-1396. Go to original source... Go to PubMed...
    15. Resnick LM. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme. J Am Soc Nephrol 1992; 3(4 Suppl): S78-85. Go to original source... Go to PubMed...
    16. Štich V, Hájek M, Horská A. Effect of very low-energy diet on muscle bioenergetics at rest and during exercise: A 31-P in vivo NMR spectroscopy study. Obesity in Europe 1991 (Ailhaud G, et al. (eds.)), 23-27. J Libbey and Comp Ltd 1991.
    17. Sedivy P, Kipfelsberger MC, Dezortova M, et al. Dynamic 31P MR spectroscopy of plantar flexion: influence of ergometer design, magnetic field strength (3 and 7 T), and RF-coil design. Med Phys 2015; 42(4): 1678-1689. Go to original source... Go to PubMed...
    18. Chmelik M, Povazan M, Jiru F, et al. Flip-angle mapping of 31P coils by steady-state magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2014; 40(2): 391-397. Go to original source... Go to PubMed...
    19. Němcová A, Dubský M, Jirkovská A, et al. Diabetic foot syndrome: importance of calf muscles MR spectroscopy in the assessment of limb ischemia and effect of revascularization. Vnitř. Lek. 2017; 63(4): 236-241. Go to original source...
    20. Horská A. Využití magnetické rezonance při diagnostice morfologických změn v myokardu. Závěrečná zpráva grantu IGA 0106-3, 1993.
    21. Kessler P. Program SOFIS pro vyhodnocování 31P MR spekter, SIB, 1990.
    22. Horská A, Frídl P, Hájek M, et al. 31P in vivo MR spectroscopy of myocardium (Czech). Prakt. Lék. 1992; 72: 103-106.
    23. Palecek T, Bultas J, Hajek M, et al. Association between cardiac energy metabolism and gain of left ventricular mass in Fabry disease. Int J Cardiol 2010; 144: 337-339. Go to original source... Go to PubMed...
    24. Tošner Z, Dezortová M, Tintěra J, Hájek M. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. Magn Reson Mater Phy 2001; 13: 40-46. Go to original source...
    25. Vyhnanovska P, Dezortova M, Herynek V, et al. In vivo 31P MR spectroscopy of human kidney grafts using the 2D-chemical shift imaging method. Transplant Proc 2011; 43(5): 1570-1575. Go to original source... Go to PubMed...
    26. Kurková D, Herynek V, Gintelová J, Táborský P, Hájek M. Potential of the 31P MR spectroscopy in monitoring of the viability of human grafts stored in euro-collins perfusion solution. Physiol Res 1995; 44: 327-332.
    27. Hájek M, Bohm F. Temperature Probe for organ examination using 31P spectroscopy and 1H MR imaging. Cryo Letters 1990; 11: 401-404.
    28. Kurkova D, Hájek M. A stable-temperature container suitable for 31P MRS and 1H MRI examination of organs in hypothermia. Cryo Letters 1994; 15: 267-268.
    29. Horská A, Vavřínková H, Hájek M, et al. Phosphate pool of isolated dog heart during global ischemia: comparison of two. Cardioplegic solutions with 31P MR spectroscopy. Physiol Res 1991; 40: 427-436.
    30. Hoult DI, Busby SJ, Gadian DG, et al. Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 1974; 252(5481): 285-287. Go to original source... Go to PubMed...
    31. Jozefovicova M, Herynek V, Jiru F, et al. 31P MR Spectroscopy of the testes and immunohistochemical analysis of sperm of transgenic boars carried n-terminal part of human mutated huntingtin. Cesk Slov Neurol N 2015; 78/111(Suppl 2): 2S28-2S33. Go to original source...
    32. Jozefovicova M, Herynek V, Jiru F, et al. Minipig model of Huntington's disease: (1) H magnetic resonance spectroscopy of the brain. Physiol Res 2016; 65(1): 155-163. Go to original source... Go to PubMed...
    33. Blahut J, Hermann P, Gálisová A, et al. Nickel(II) complexes of N-CH2CF3 cyclam derivatives as contrast agents for 19F magnetic resonance imaging. Dalton Trans 2016; 45(2): 474-478. Go to original source... Go to PubMed...
    34. Herynek V, Martinisková M, Gálisová A, et al. Contrast agents with chelated lanthanoid ions for 19F MR imaging. Proc Intl Soc Mag Reson Med 2014; 22: 3837.
    35. Herynek V, Gálisová A, Blahut J, et al. A probe for a combined 1H and 19F in vivo MRI. World Molecular Imaging Meeting, NY 2016; control ID 2493856.
    36. Srinivas M, Cruz LJ, Bonetto F, et al. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials 2010; 31(27): 7070-7077. Go to original source... Go to PubMed...
    37. Herynek V, Gálisová A, Srinivas M, et al. Pre-microporation improves outcome of pancreatic islet labelling for optical and 19F MR imaging. Biological Procedures Online 2017; 19: 6. Go to original source... Go to PubMed...
    38. Jirák D, Gálisová A, Sedláček O, Hrubý M, Hájek M. A novel theranostic termoresponsive 19F probe for tumor imaging. Proc Intl Soc Mag Reson Med 2017; 25: 3588.

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content